Product Categories
Country: | China |
---|---|
Tel: | 0316-2883536 |
Mobile: | 19333636468 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
Thieno[3,2-c]pyridinium, 5-[(2-chlorophenyl)methyl]-6,7-dihydro-, bromide (1:1) | C14H13BrClNS | 2418591-13-4 | Details |
Vildagliptin Impurity 53 | C7H10N2O | 700376-84-7 | Details |
(Z)-1-(6-methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl)ethanone oxime | C15H16N2O3S | 1810761-43-3 | Details |
Vildagliptin Impurity 25 | C7H10N2O2 | 1563006-28-9 | Details |
Methyl2-(2-chlorophenyl)-2-(4,5-dihydrothieno[2,3-c]pyridin-6(7H)-yl)acetatehydrochloride | C16H16ClNO2S.ClH | 144750-52-7 | Details |
(2S)-2-amino-3-(2-chlorophenyl)propanamide | C9H11ClN2O | 2381221-17-4 | Details |
Nidanib Impurity 7 | C13H20N4O | 262368-25-2 | Details |
N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide | C14H20N4O3 | 1139453-98-7 | Details |
Methyl 2-(2-chlorophenyl)-2-oxoacetate | C9H7ClO3 | 34966-49-9 | Details |
rac-Clopidogrel Carboxylic Acid | C15H14ClNO2S | 90055-55-3 | Details |
Vildagliptin Related Compound F | C17H24N2O3 | 1789703-36-1 | Details |
vildagliptin Impurity Q | C7H10Cl2N2O2 | 1803168-08-2 | Details |
1-(2-chlorophenyl)-2-ethoxyethanamine | C10H14ClNO | 1485619-90-6 | Details |
Vildagliptin IMpurity 2 (Mixture of DiastereoMers) | C24H33N5O3 | 1036959-23-5 | Details |
(R)-1-(2-chloroacetyl)pyrrolidine-2-carboxaMide | C7H11ClN2O2 | 1211679-98-9 | Details |
BIBF 1202 | C30H31N5O4 | 894783-71-2 | Details |
vildagliptin Impurity V | C12H19NO3 | 1032564-18-3 | Details |
1-(4-CHLOROPHENYL)-2-METHOXY-2-OXO-1-ETHANAMINIUM CHLORIDE | C9H11Cl2NO2 | 42718-19-4 | Details |
Etoricoxib Impurity O | C15H15NO2S | 307531-95-9 | Details |
Clopidogrel Impurity 22 | C8H9ClN2O | 138228-61-2 | Details |
Etoricoxib Impurity 9 | C13H17NO3S2 | 859824-65-0 | Details |
Clopidogrel | C15H16ClNO2S | 1314028-89-1 | Details |
Nintedanib-013-CO | C17H13NO4 | 2218446-42-3 | Details |
H-D-PHG-OME HCL | C9H12ClNO2 | 19883-41-1 | Details |
Ticlopidine EP Impurity E Bromide | C14H11BrClNS | 73099-88-4 | Details |
(11β,16β)-9-BroMo-11-hydroxy-16-Methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione | C28H37BrO7 | 52092-14-5 | Details |
3-Amino-4-(carboxymethyl)benzoic acid | C9H9NO4 | 1373232-85-9 | Details |
Prasugrel | C18H18FNOS | 201049-78-7 | Details |
Clopidogrel Impurity O | C17H20ClNO6S2 | 1332612-57-3 | Details |
Vildagliptin Impurity ZA6 | C17H23N3O2 | 2246354-69-6 | Details |
Nintedanib Impurity 52 | C22H30N6O2 | 2410284-89-6 | Details |
Pregna-1,4-diene-3,20-dione, 11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11β,16β)- | C28H38O7 | 71934-47-9 | Details |
vildagliptin Impurity J | C7H9ClN2O | 207557-35-5 | Details |
Acetamide, 2,2,2-trichloro-N-methyl-N-(4-nitrophenyl)- | C9H7Cl3N2O3 | 126434-07-9 | Details |
1-Piperazinecarboxylic acid, 4-[2-[methyl(4-nitrophenyl)amino]-2-oxoethyl]-, 1,1-dimethylethyl ester | C18H26N4O5 | 1277571-69-3 | Details |
Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, ethyl ester | C17H18ClNO2S | 90055-81-5 | Details |
Vildagliptin Carboxylic Acid | C17H26N2O4 | 565453-40-9 | Details |
Etoricoxib Impurity 8 | C22H20N2O4S | 1421227-97-5 | Details |
Etoricoxib Impurity 13 | C25H20ClN3O3S | 1817735-82-2 | Details |
vildagliptin Impurity R | C7H8Cl2N2O | 1803168-09-3 | Details |
(S) - 2 - (2-chlorophenyl) - 2 - ((2 - (thiophene-2-yl) ethyl) amino) methyl acetate hydrochloride | C15H17Cl2NO2S | 141109-19-5 | Details |
Clobetasone butyrate EP Impurity H | C25H30ClFO5 | 25122-56-9 | Details |
N-(4-Nitrophenyl)-2,2,2-trichloroacetamide | C8H5Cl3N2O3 | 4306-32-5 | Details |
BetaMethasone 9,11-Epoxide 17-Propionate | C25H32O6 | 79578-39-5 | Details |
2-Methyl-5-(3-(4-(Methylsulfonyl)phenyl)furan-2-yl)pyridine | C17H15NO3S | 307531-96-0 | Details |
Etoricoxib Impurity 11 | C17H13ClN2O2S | 202409-31-2 | Details |
Clopidogrel EP Impurity F (R-Isomer) | 1258938-54-3 | Details |
2-OXO-2,3-DIHYDRO-1H-INDOLE-6-CARBOXYLIC ACID | C9H7NO3 | 334952-09-9 | Details |
N1-(4-NITROPHENYL)-2-CHLOROACETAMIDE | C8H7ClN2O3 | 17329-87-2 | Details |
(S)-2-(2-Chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)aceticacid(ClopidogrelImpurity) | C14H14ClNO2S | 1015247-87-6 | Details |
(S)-1-N-CBZ-2-CYANO-PYRROLIDINE | C13H14N2O2 | 63808-36-6 | Details |
1H-Indole-6-carboxylic acid, 3-[[[4-[(2-chloroacetyl)methylamino]phenyl]amino]phenylmethylene]-2,3-dihydro-2-oxo-, methyl ester, (3Z)- | C26H22ClN3O4 | 1987887-93-3 | Details |
BetaMethasone 9,11-Epoxide 17,21-Dipropionate | C28H36O7 | 66917-44-0 | Details |
5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide | C18H15ClN2O3S | 325855-74-1 | Details |
N-(4-aMinophenyl)-2-chloro-N-MethylacetaMide | C9H11ClN2O | 855860-75-2 | Details |
6'-DesMethyl-6'-carboxy Etoricoxib | C18H13ClN2O4S | 349536-39-6 | Details |
Clopidogrel Impurity 28 | C13H14O3S2 | 40412-09-7 | Details |
Vildagliptin Related Compound A | C17H25N3O | 741657-02-3 | Details |
Etoricoxib Impurity 18 | C15H15NO4S | 1027162-35-1 | Details |
Benzeneacetic acid, α-amino-2-chloro-, ethyl ester, hydrochloride (1:1), (αS)- | C10H13Cl2NO2 | 2649375-64-2 | Details |
2-CHLORO-N-METHYL-N-(4-NITROPHENYL)ACETAMIDE | C9H9ClN2O3 | 2653-16-9 | Details |
Vildagliptin Impurity 42 | C5H8N2 | 204387-53-1 | Details |
vildagliptin Impurity U | C8H12ClNO3 | 38074-72-5 | Details |
Ticlopidine Impurity 2(Ticlopidine EP Impurity B) | C7H7NOS | 68559-60-4 | Details |
6'-DesMethyl-6'-Methylhydroxy Etoricoxib | C18H15ClN2O3S | 349536-41-0 | Details |
Etoricoxib Impurity 36 | C13H17NO4S | 1798110-01-6 | Details |
Clopidogrel EP I | C15H14ClNO2S.ClH | 144750-42-5 | Details |
Vildagliptin Carboxylic Acid Methyl Ester | C18H28N2O4 | 948574-56-9 | Details |
4-Amino-N-methylaniline | C7H10N2 | 623-09-6 | Details |
Beclomethasone | C22H29ClO5 | 4419-39-0 | Details |
D-ProlinaMide | C5H10N2O | 62937-45-5 | Details |
Clopidogrel EP Impurity F | C15H16ClNO2S | 141109-20-8 | Details |
Clopidogrel bisulfate impurity P | C16H15BrClNO2S | 2418591-12-3 | Details |
Acetamide, 2-chloro-N-methyl-N-(2-nitrophenyl)- | C9H9ClN2O3 | 2653-15-8 | Details |
Vildagliptin Chloroacetyl Nitrile (R)-Isomer | C7H9ClN2O | 565452-98-4 | Details |
Acetamide, 2-hydroxy-N-methyl-N-(4-nitrophenyl)- | C9H10N2O4 | 1860012-61-8 | Details |
Nintedanib Impurity 30 | C13H18N4O3 | 1038972-16-5 | Details |
Vildagliptin Impurity 18 | C7H10ClNO3 | 23500-10-9 | Details |
Clopidogrel Impurity 25 | C15H17Cl2NO2S | 141109-18-4 | Details |
Clopidogrel EP IMpurity D | C24H21Cl2NO4S | 1421283-60-4 | Details |
Vildagliptin Impurity 2 | C7H11ClN2O2 | 214398-99-9 | Details |
Clopidogrel Impurity 52 | C16H16ClNO3S | 1147350-75-1 | Details |
Beclomethasone Dipropionate Impurity | C28H36O6 | 52092-12-3 | Details |
Clopidogrel IMpurity 2 (Clopidogrel IMiniuM IMpurity) | C16H15ClNO2S.Br | 1396607-49-0 | Details |
Etoricoxib Impurity 10 | C18H15ClN2OS | 316149-01-6 | Details |
Nintedanib impurity E | C29H31N5O2 | 262366-32-5 | Details |
Clopidogrel Impurity C | C16H18ClNO2S | 1346605-15-9 | Details |
N-ACETYLOXINDOLE 97 | C10H9NO2 | 21905-78-2 | Details |
1-Piperazineacetamide, N-(4-aminophenyl)-N-methyl- | C13H20N4O | 2243384-71-4 | Details |
Etoricoxib Impurity 47 | C18H15NO4S | 2241145-66-2 | Details |
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-9-bromo-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (11β,16β)- (9CI) | C27H35BrO7 | 52092-15-6 | Details |
Clopidogrel Impurity 3 | C14H11Cl2NS | 53885-64-6 | Details |
vildagliptin Impurity Isomer | C17H25N3O2 | 1036959-27-9 | Details |
Vildagliptin iMpurity K | C17H27N3O3 | 565453-39-6 | Details |
Vildagliptin Related Compound H | C12H16N4O | 2253194-13-5 | Details |
METHYL AMINO(3-CHLOROPHENYL)ACETATE HYDROCHLORIDE | C9H11Cl2NO2 | 1351586-91-8 | Details |
vildagliptin Impurity E | C17H25N3O2 | 1789703-37-2 | Details |
Clopidogrel EP Impurity E | C15H15ClN2OS | 90055-68-8 | Details |
Vildagliptin Impurity 57 | C7H12ClN3O | 913980-23-1 | Details |
Vildagliptin Impurity 13 | C6H11NO2 | 2577-48-2 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 |